What it is
Mesenchymal stromal cells, often called MSCs, are a type of cell that researchers have studied for many years. They can be collected from sources such as bone marrow, fat tissue, or umbilical cord tissue. An MSC clinical research site is a practice, hospital, or academic center that studies these cells in a structured research setting.
Research at these sites is investigational. That means the cells are being studied to learn about safety and whether they may help, not offered as proven care. A legitimate study follows a written protocol, is registered on ClinicalTrials.gov, and is reviewed by an Institutional Review Board (IRB), an independent group that helps protect participants.
It is important to be precise about regulation. In the U.S., the only FDA-approved stem-cell products are cord-blood-derived hematopoietic progenitor cell (HPC) products for certain blood and immune disorders, used in specialist transplant settings. Most other stem cell products, including MSC, adipose or SVF, umbilical cord, Wharton's jelly, perinatal, and exosome products, are not FDA-approved, and no exosome product is FDA-approved. The FDA has warned the public about unapproved stem cell and exosome products.
How it’s traditionally been approached
Medical research has traditionally moved in stages, with questions about safety and how a product behaves in the body asked before broader questions are studied. Research is carried out by investigators who follow a written plan and report to oversight bodies. Many studies are run by physicians at academic centers or physician-led practices.
In the U.S., products intended to treat disease generally must go through FDA review, and studies of investigational products typically operate under FDA oversight. Participants are usually screened against eligibility criteria that the study defines. Sites also keep records and report concerns as part of their oversight duties.
Informed consent is a cornerstone of this process. It is a written document and conversation that explains the purpose of the study, known and possible risks, alternatives, and the right to leave at any time. Evidence for MSC uses is generally described as limited or still emerging, and results from one study do not automatically apply to every person or condition.
How the right provider may help
The right provider or research team may help you understand whether a study is legitimate and whether it could be relevant to your situation. A first conversation is often a screening discussion, where staff review the study's purpose, eligibility criteria, and what participation would involve. Only a licensed clinician can decide what is appropriate for you after an evaluation.
Good questions to ask include: What is the ClinicalTrials.gov registration number? Which IRB oversees the study? Is the product FDA-approved, or is it being studied under FDA oversight? What are the risks, the alternatives, and what happens if I decide to leave? You can also ask who pays for study-related care and whether you may keep your regular doctor informed.
Take your time and bring a trusted person if you like. You can verify the clinician's license with your state medical board and look up the study yourself on ClinicalTrials.gov. A trustworthy team should welcome these checks and give you written informed consent materials to review before you decide.
The whole-person view
Health is a whole-person experience. Body, mind, and stress affect each other, and facing a long-term health concern or considering an experimental option can bring hope, worry, and pressure all at once. Paying attention to sleep, movement, support, and stress may be part of feeling steadier while you make decisions.
Some people explore body-based support such as Somatic Experiences to help them tune in to how stress shows up physically. Others find talk therapy through Therapists.plus useful for sorting through big decisions and uncertainty. These are complementary supports, not substitutes for care from a licensed clinician.
Somatic Experiences: embodiment and movement →Somatic Experiences: nervous system regulation →Therapists.plus: mind body connection →
Keep in mind
- Verify a product's FDA status, confirm the study is registered on ClinicalTrials.gov with IRB oversight, and check the clinician's license with your state medical board.
- Red flags include cure-all or 'treats everything' claims, paying to join a 'clinical trial', testimonials offered in place of evidence, and pressure to travel abroad or across states for treatment. 'Holistic' or 'alternative' framing does not change FDA status.
- Never accept claims of cures, tissue or cartilage regrowth, or avoiding surgery, and be cautious of any quoted success rates. Licensed professionals should guide care for serious conditions, and you should get written informed consent that covers risks and alternatives.
- For emergencies call 911; in a crisis call or text the 988 Lifeline.
A legitimate trial is registered on ClinicalTrials.gov and overseen by an IRB; paying to join a 'trial' is a red flag.
Providers
We’re welcoming founding providers for msc clinical research sites now. Get matched or list your practice.
Frequently asked questions
What is an MSC clinical research site?
An MSC clinical research site is a physician-led practice, hospital, or academic center that studies mesenchymal stromal cells under a written protocol. Legitimate sites register studies on ClinicalTrials.gov and operate with IRB oversight. The work is investigational, meaning the cells are being studied rather than offered as proven care.
Is stem cell therapy with MSCs FDA-approved?
No, MSC treatments are not FDA-approved for general clinic use. In the U.S., the only FDA-approved stem-cell products are cord-blood-derived hematopoietic progenitor cell (HPC) products for certain blood and immune disorders, used in specialist transplant settings. The FDA has warned the public about unapproved stem cell products, so ask any provider about a product's regulatory status.
How can I tell if a stem cell therapy trial is legitimate?
A legitimate trial is registered on ClinicalTrials.gov and overseen by an IRB. You can look up the registration number yourself, confirm the clinician's license with your state medical board, and review written informed consent materials. If anything cannot be verified, consider that a reason to pause.
Should I pay to join a stem cell clinical trial?
Paying to join a so-called trial is a red flag. Legitimate research generally does not charge participants for the investigational product itself, though study details vary, so ask the team to explain in writing what you would be responsible for. Be cautious of anyone who blurs the line between research and a paid treatment.
What is informed consent in a clinical trial?
Informed consent is a written document and conversation that explains a study's purpose, possible risks, alternatives, and your right to leave at any time. You should receive it to review before deciding, and you can ask questions. It should never be rushed or used to pressure you.
Are exosome products approved by the FDA?
No, no exosome product is FDA-approved, and the FDA has warned the public about unapproved exosome products. Claims that exosomes treat a wide range of conditions should be viewed with caution. Ask a licensed clinician about the regulatory status and any registered research.
Educational resource. StemCell.biz shares general information and connects people with independent providers. It is not medical advice, diagnosis or treatment. Talk with a licensed professional about your health.